Novo Nordisk Sheds 3% After Ousting CEO As Eli Lilly Rivalry Slams Stock Price
In This Article:
Novo Nordisk said Friday it will replace its CEO, citing a sharp tumble for Novo shares amid growing competition.
Oops, something went wrong
Novo Nordisk said Friday it will replace its CEO, citing a sharp tumble for Novo shares amid growing competition.